Výsledky vyhledávání - "Multicenter Studies as Topic [MeSH]"

  1. 1

    Zdroj: Developmental Cognitive Neuroscience. 70

    Témata: 32 Biomedical and Clinical Sciences (for-2020), 3209 Neurosciences (for-2020), Biomedical Imaging (rcdc), Mental Health (rcdc), Behavioral and Social Science (rcdc), Clinical Research (rcdc), Neurosciences (rcdc), Basic Behavioral and Social Science (rcdc), Pediatric (rcdc), 4.1 Discovery and preclinical testing of markers and technologies (hrcs-rac), Generic health relevance (hrcs-hc), Child (mesh), Child, Preschool (mesh), Female (mesh), Humans (mesh), Infant (mesh), Infant, Newborn (mesh), Male (mesh), Brain (mesh), Child Development (mesh), Longitudinal Studies (mesh), Magnetic Resonance Imaging (mesh), Magnetic Resonance Spectroscopy (mesh), Neuroimaging (mesh), Prospective Studies (mesh), Multicenter Studies as Topic (mesh), HBCD, Infant, MRI, MRS, Development, Protocol, HBCD MRI Working Group, Brain (mesh), Humans (mesh), Magnetic Resonance Imaging (mesh), Magnetic Resonance Spectroscopy (mesh), Longitudinal Studies (mesh), Prospective Studies (mesh), Child Development (mesh), Child (mesh), Child, Preschool (mesh), Infant (mesh), Infant, Newborn (mesh), Female (mesh), Male (mesh), Multicenter Studies as Topic (mesh), Neuroimaging (mesh), Development, HBCD, Infant, MRI, MRS, Protocol, Child (mesh), Child, Preschool (mesh), Female (mesh), Humans (mesh), Infant (mesh), Infant, Newborn (mesh), Male (mesh), Brain (mesh), Child Development (mesh), Longitudinal Studies (mesh), Magnetic Resonance Imaging (mesh), Magnetic Resonance Spectroscopy (mesh), Neuroimaging (mesh), Prospective Studies (mesh), Multicenter Studies as Topic (mesh), 1103 Clinical Sciences (for), 1109 Neurosciences (for), 1702 Cognitive Sciences (for), 3209 Neurosciences (for-2020), 5202 Biological psychology (for-2020), 5203 Clinical and health psychology (for-2020)

    Popis souboru: application/pdf

  2. 2
  3. 3

    Zdroj: Trials. 25(1)

    Témata: 3214 Pharmacology and Pharmaceutical Sciences (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 42 Health Sciences (for-2020), Brain Disorders (rcdc), Behavioral and Social Science (rcdc), Clinical Research (rcdc), Methamphetamine (rcdc), Substance Misuse (rcdc), Clinical Trials and Supportive Activities (rcdc), Patient Safety (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Mental health (hrcs-hc), 3 Good Health and Well Being (sdg), Humans (mesh), Mirtazapine (mesh), Double-Blind Method (mesh), Amphetamine-Related Disorders (mesh), Methamphetamine (mesh), Adult (mesh), Middle Aged (mesh), Adolescent (mesh), Clinical Trials, Phase III as Topic (mesh), Male (mesh), Young Adult (mesh), Randomized Controlled Trials as Topic (mesh), Aged (mesh), Female (mesh), Treatment Outcome (mesh), Multicenter Studies as Topic (mesh), Australia (mesh), Time Factors (mesh), Medication Adherence (mesh), Antidepressive Agents, Tricyclic (mesh), Substance use disorders, Methamphetamine, Mirtazapine, Clinical trial, Depression, Sleep, Pharmacotherapy, Treatment, Psychiatry, Addiction, Humans (mesh), Amphetamine-Related Disorders (mesh), Methamphetamine (mesh), Antidepressive Agents, Tricyclic (mesh), Treatment Outcome (mesh), Double-Blind Method (mesh), Time Factors (mesh), Adolescent (mesh), Adult (mesh), Aged (mesh), Middle Aged (mesh), Australia (mesh), Female (mesh), Male (mesh), Multicenter Studies as Topic (mesh), Randomized Controlled Trials as Topic (mesh), Clinical Trials, Phase III as Topic (mesh), Medication Adherence (mesh), Young Adult (mesh), Mirtazapine (mesh), Addiction, Clinical trial, Depression, Methamphetamine, Mirtazapine, Pharmacotherapy, Psychiatry, Sleep, Substance use disorders, Treatment, Humans (mesh), Mirtazapine (mesh), Double-Blind Method (mesh), Amphetamine-Related Disorders (mesh), Methamphetamine (mesh), Adult (mesh), Middle Aged (mesh), Adolescent (mesh), Clinical Trials, Phase III as Topic (mesh), Male (mesh), Young Adult (mesh), Randomized Controlled Trials as Topic (mesh), Aged (mesh), Female (mesh), Treatment Outcome (mesh), Multicenter Studies as Topic (mesh), Australia (mesh), Time Factors (mesh), Medication Adherence (mesh), Antidepressive Agents, Tricyclic (mesh), 1102 Cardiorespiratory Medicine and Haematology (for), 1103 Clinical Sciences (for), Cardiovascular System & Hematology (science-metrix), General & Internal Medicine (science-metrix), 3202 Clinical sciences (for-2020), 4202 Epidemiology (for-2020), 4203 Health services and systems (for-2020)

    Popis souboru: application/pdf

  4. 4

    Zdroj: BMJ Open. 13(11)

    Témata: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Organ Transplantation (rcdc), Kidney Disease (rcdc), Transplantation (rcdc), Liver Disease (rcdc), Clinical Trials and Supportive Activities (rcdc), Cardiovascular (rcdc), Clinical Research (rcdc), Hypertension (rcdc), Digestive Diseases (rcdc), 6.1 Pharmaceuticals (hrcs-rac), Oral and gastrointestinal (hrcs-hc), Adult (mesh), Humans (mesh), Angiotensin II (mesh), Liver Transplantation (mesh), End Stage Liver Disease (mesh), Severity of Illness Index (mesh), Living Donors (mesh), Vasoconstrictor Agents (mesh), Hypotension (mesh), Norepinephrine (mesh), Double-Blind Method (mesh), Catecholamines (mesh), Randomized Controlled Trials as Topic (mesh), Multicenter Studies as Topic (mesh), Angiotensin II, Liver Transplantation, Vasoconstrictor agents, End Stage Liver Disease, Liver Cirrhosis, Blood Pressure, Humans (mesh), Hypotension (mesh), Norepinephrine (mesh), Catecholamines (mesh), Angiotensin II (mesh), Vasoconstrictor Agents (mesh), Liver Transplantation (mesh), Severity of Illness Index (mesh), Double-Blind Method (mesh), Adult (mesh), Living Donors (mesh), Multicenter Studies as Topic (mesh), Randomized Controlled Trials as Topic (mesh), End Stage Liver Disease (mesh), Angiotensin II, Blood Pressure, End Stage Liver Disease, Liver Cirrhosis, Liver Transplantation, Vasoconstrictor agents, Adult (mesh), Humans (mesh), Angiotensin II (mesh), Liver Transplantation (mesh), End Stage Liver Disease (mesh), Severity of Illness Index (mesh), Living Donors (mesh), Vasoconstrictor Agents (mesh), Hypotension (mesh), Norepinephrine (mesh), Double-Blind Method (mesh), Catecholamines (mesh), Randomized Controlled Trials as Topic (mesh), Multicenter Studies as Topic (mesh), 1103 Clinical Sciences (for), 1117 Public Health and Health Services (for), 1199 Other Medical and Health Sciences (for), 32 Biomedical and clinical sciences (for-2020), 42 Health sciences (for-2020), 52 Psychology (for-2020)

    Popis souboru: application/pdf

  5. 5

    Zdroj: International Journal of Radiation Oncology • Biology • Physics. 116(2)

    Témata: 5105 Medical and Biological Physics (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 51 Physical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Infectious Diseases (rcdc), Cancer (rcdc), Radiation Oncology (rcdc), Sexually Transmitted Infections (rcdc), Clinical Trials and Supportive Activities (rcdc), HIV/AIDS (rcdc), Clinical Research (rcdc), Cervical Cancer (rcdc), Women's Health (rcdc), Female (mesh), Humans (mesh), Cisplatin (mesh), Acquired Immunodeficiency Syndrome (mesh), Brachytherapy (mesh), Radiotherapy Dosage (mesh), Africa South of the Sahara (mesh), Neoplasms (mesh), Uterine Cervical Neoplasms (mesh), Neoplasm Staging (mesh), Multicenter Studies as Topic (mesh), Humans (mesh), Acquired Immunodeficiency Syndrome (mesh), Neoplasms (mesh), Cisplatin (mesh), Neoplasm Staging (mesh), Brachytherapy (mesh), Radiotherapy Dosage (mesh), Africa South of the Sahara (mesh), Uterine Cervical Neoplasms (mesh), Female (mesh), Multicenter Studies as Topic (mesh), Female (mesh), Humans (mesh), Cisplatin (mesh), Acquired Immunodeficiency Syndrome (mesh), Brachytherapy (mesh), Radiotherapy Dosage (mesh), Africa South of the Sahara (mesh), Neoplasms (mesh), Uterine Cervical Neoplasms (mesh), Neoplasm Staging (mesh), Multicenter Studies as Topic (mesh), 0299 Other Physical Sciences (for), 1103 Clinical Sciences (for), 1112 Oncology and Carcinogenesis (for), Oncology & Carcinogenesis (science-metrix), 3211 Oncology and carcinogenesis (for-2020), 3407 Theoretical and computational chemistry (for-2020), 5105 Medical and biological physics (for-2020)

    Popis souboru: application/pdf

  6. 6

    Zdroj: Journal of the American College of Cardiology. 81(15)

    Popis souboru: application/pdf

  7. 7
  8. 8

    Zdroj: NeuroImage Clinical. 40

    Popis souboru: application/pdf

  9. 9

    Zdroj: PLOS ONE. 18(6)

    Popis souboru: application/pdf

  10. 10
  11. 11
  12. 12

    Přispěvatelé: Turella, Sara Dankiewicz, Josef Friberg, Hans a další

    Zdroj: Intensive Care Med
    Intensive care medicine, vol. 50, no. 1, pp. 90-102
    Turella, S, Dankiewicz, J, Friberg, H, Jakobsen, J C, Leithner, C, Levin, H, Lilja, G, Moseby-Knappe, M, Nielsen, N, Rossetti, A O, Sandroni, C, Zubler, F, Cronberg, T, Westhall, E, TTM2 Trial Investigators & Lange, T 2024, ' The predictive value of highly malignant EEG patterns after cardiac arrest : evaluation of the ERC-ESICM recommendations ', Intensive Care Medicine, vol. 50, no. 1, pp. 90-102 . https://doi.org/10.1007/s00134-023-07280-9
    Turella, Sara; Dankiewicz, Josef; Friberg, Hans; Jakobsen, Janus Christian; Leithner, Christoph; Levin, Helena; Lilja, Gisela; Moseby-Knappe, Marion; Nielsen, Niklas; Rossetti, Andrea O; Sandroni, Claudio; Zubler, Frédéric; Cronberg, Tobias; Westhall, Erik (2024). The predictive value of highly malignant EEG patterns after cardiac arrest: evaluation of the ERC-ESICM recommendations. Intensive care medicine, 50(1), pp. 90-102. Springer 10.1007/s00134-023-07280-9 <http://dx.doi.org/10.1007/s00134-023-07280-9>

    Popis souboru: application/pdf

  13. 13

    Zdroj: Molecular Psychiatry. 27(6)

    Popis souboru: application/pdf

  14. 14

    Zdroj: BMJ Open. 11(12)

    Témata: 4203 Health Services and Systems (for-2020), 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 42 Health Sciences (for-2020), Clinical Research (rcdc), Clinical Trials and Supportive Activities (rcdc), Cardiovascular (rcdc), Heart Disease (rcdc), 7.1 Individual care needs (hrcs-rac), 6.3 Medical devices (hrcs-rac), 7.3 Management and decision making (hrcs-rac), Cardiovascular (hrcs-hc), 3 Good Health and Well Being (sdg), Atrial Fibrillation (mesh), Atrial Flutter (mesh), Electric Countershock (mesh), Humans (mesh), Multicenter Studies as Topic (mesh), Pragmatic Clinical Trials as Topic (mesh), Prospective Studies (mesh), Quality of Life (mesh), Randomized Controlled Trials as Topic (mesh), Humans (mesh), Atrial Fibrillation (mesh), Atrial Flutter (mesh), Electric Countershock (mesh), Prospective Studies (mesh), Quality of Life (mesh), Multicenter Studies as Topic (mesh), Randomized Controlled Trials as Topic (mesh), Pragmatic Clinical Trials as Topic (mesh), adult cardiology, pacing & electrophysiology, telemedicine, Atrial Fibrillation (mesh), Atrial Flutter (mesh), Electric Countershock (mesh), Humans (mesh), Multicenter Studies as Topic (mesh), Pragmatic Clinical Trials as Topic (mesh), Prospective Studies (mesh), Quality of Life (mesh), Randomized Controlled Trials as Topic (mesh), 1103 Clinical Sciences (for), 1117 Public Health and Health Services (for), 1199 Other Medical and Health Sciences (for), 32 Biomedical and clinical sciences (for-2020), 42 Health sciences (for-2020), 52 Psychology (for-2020)

    Popis souboru: application/pdf

  15. 15

    Zdroj: BMC Cancer. 21(1)

    Témata: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Precision Medicine (rcdc), Patient Safety (rcdc), Clinical Research (rcdc), Bioengineering (rcdc), Clinical Trials and Supportive Activities (rcdc), Health Disparities (rcdc), Urologic Diseases (rcdc), Minority Health (rcdc), Prostate Cancer (rcdc), Aging (rcdc), Biomedical Imaging (rcdc), Radiation Oncology (rcdc), Cancer (rcdc), 4.2 Evaluation of markers and technologies (hrcs-rac), Cancer (hrcs-hc), Humans (mesh), Male (mesh), Antigens, Surface (mesh), Glutamate Carboxypeptidase II (mesh), Positron Emission Tomography Computed Tomography (mesh), Prospective Studies (mesh), Prostatic Neoplasms (mesh), Radiotherapy Planning, Computer-Assisted (mesh), Clinical Trials, Phase III as Topic (mesh), Multicenter Studies as Topic (mesh), Randomized Controlled Trials as Topic (mesh), Prostate cancer, PSMA, PET/CT, Randomized phase 3 trial, Definitive radiation therapy, Humans (mesh), Prostatic Neoplasms (mesh), Glutamate Carboxypeptidase II (mesh), Antigens, Surface (mesh), Radiotherapy Planning, Computer-Assisted (mesh), Prospective Studies (mesh), Male (mesh), Multicenter Studies as Topic (mesh), Randomized Controlled Trials as Topic (mesh), Clinical Trials, Phase III as Topic (mesh), Positron Emission Tomography Computed Tomography (mesh), Definitive radiation therapy, PET/CT, PSMA, Prostate cancer, Randomized phase 3 trial, Humans (mesh), Male (mesh), Antigens, Surface (mesh), Glutamate Carboxypeptidase II (mesh), Positron Emission Tomography Computed Tomography (mesh), Prospective Studies (mesh), Prostatic Neoplasms (mesh), Radiotherapy Planning, Computer-Assisted (mesh), Clinical Trials, Phase III as Topic (mesh), Multicenter Studies as Topic (mesh), Randomized Controlled Trials as Topic (mesh), 1112 Oncology and Carcinogenesis (for), 1117 Public Health and Health Services (for), Oncology & Carcinogenesis (science-metrix), 3211 Oncology and carcinogenesis (for-2020), 4202 Epidemiology (for-2020)

    Popis souboru: application/pdf

  16. 16

    Zdroj: American Heart Journal. 232

    Témata: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), Clinical Research (rcdc), Patient Safety (rcdc), Clinical Trials and Supportive Activities (rcdc), Cardiovascular (hrcs-hc), 3 Good Health and Well Being (sdg), COVID-19 (mesh), Clopidogrel (mesh), Continuity of Patient Care (mesh), Feasibility Studies (mesh), Follow-Up Studies (mesh), Genotype (mesh), Geographic Information Systems (mesh), Health Surveys (mesh), Humans (mesh), Internet-Based Intervention (mesh), Ischemia (mesh), Mobile Applications (mesh), Multicenter Studies as Topic (mesh), Patient Compliance (mesh), Patient Generated Health Data (mesh), Patient Participation (mesh), Percutaneous Coronary Intervention (mesh), Postoperative Complications (mesh), Pragmatic Clinical Trials as Topic (mesh), Purinergic P2Y Receptor Antagonists (mesh), Randomized Controlled Trials as Topic (mesh), Registries (mesh), Research Design (mesh), SARS-CoV-2 (mesh), Telephone (mesh), Humans (mesh), Ischemia (mesh), Postoperative Complications (mesh), Health Surveys (mesh), Registries (mesh), Follow-Up Studies (mesh), Feasibility Studies (mesh), Patient Compliance (mesh), Genotype (mesh), Research Design (mesh), Telephone (mesh), Geographic Information Systems (mesh), Patient Participation (mesh), Continuity of Patient Care (mesh), Multicenter Studies as Topic (mesh), Randomized Controlled Trials as Topic (mesh), Purinergic P2Y Receptor Antagonists (mesh), Percutaneous Coronary Intervention (mesh), Mobile Applications (mesh), Pragmatic Clinical Trials as Topic (mesh), Patient Generated Health Data (mesh), Clopidogrel (mesh), Internet-Based Intervention (mesh), COVID-19 (mesh), SARS-CoV-2 (mesh), COVID-19 (mesh), Clopidogrel (mesh), Continuity of Patient Care (mesh), Feasibility Studies (mesh), Follow-Up Studies (mesh), Genotype (mesh), Geographic Information Systems (mesh), Health Surveys (mesh), Humans (mesh), Internet-Based Intervention (mesh), Ischemia (mesh), Mobile Applications (mesh), Multicenter Studies as Topic (mesh), Patient Compliance (mesh), Patient Generated Health Data (mesh), Patient Participation (mesh), Percutaneous Coronary Intervention (mesh), Postoperative Complications (mesh), Pragmatic Clinical Trials as Topic (mesh), Purinergic P2Y Receptor Antagonists (mesh), Randomized Controlled Trials as Topic (mesh), Registries (mesh), Research Design (mesh), SARS-CoV-2 (mesh), Telephone (mesh), 1102 Cardiorespiratory Medicine and Haematology (for), 1117 Public Health and Health Services (for), Cardiovascular System & Hematology (science-metrix), 3201 Cardiovascular medicine and haematology (for-2020)

    Popis souboru: application/pdf

  17. 17
  18. 18

    Zdroj: BMC Public Health
    BMC Public Health, Vol 24, Iss 1, Pp 1-19 (2024)

    Popis souboru: application/pdf

  19. 19

    Zdroj: Trials
    Trials, Vol 25, Iss 1, Pp 1-10 (2024)

  20. 20

    Zdroj: Trials
    Trials, Vol 25, Iss 1, Pp 1-15 (2024)
    Trials 25, 760 (2024). doi:10.1186/s13063-024-08566-z